Skip to Main Content

This is a test.

Studying the evolution of high-grade serous ovarian cancer after targeted therapy

This is a test.

Identifying biomarkers of immunotherapy response in ovarian clear cell carcinoma

This is a test.

Testing a novel HER2-targeted combination treatment for ovarian cancer

This is a test.

Anti-estrogen therapy and ER/PR expression in low-grade serous ovarian cancer

This is a test.

Testing a novel treatment target in clear cell ovarian cancer

This is a test.

NEOCATS trial: Targeting the targets with a combination of three treatments

This is a test.

ES2 trial: combining a PARP inhibitor and apoptosis sensitizer

This is a test.

Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor

This is a test.

Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor

This is a test.

Developing new treatments for clear cell ovarian cancer